help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 18, 2003
Endocrinology, doi:10.1210/en.2003-0568
A more recent version of this article appeared on January 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/1/134    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Matusik, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Matusik, R. J.

Submitted on May 7, 2003
Accepted on September 10, 2003

An Androgen Dependent Upstream Enhancer Is Essential for High Levels of Probasin Gene Expression

JianFeng Zhang1, Nan Gao1, Susan Kasper1, Kimberly Reid1, Colleen Nelson1, and Robert J. Matusik1*

1 Department of Urologic Surgery, Department of Cell and Developmental Biology, Department of Cancer Biology, The Vanderbilt Prostate Cancer Center, The Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232-2765, The Prostate Centre, The Jack Bell Research Centre, 2660 Oak Street, Vancouver, BC Canada V6H 3Z6

* To whom correspondence should be addressed. E-mail: robert.matusik{at}vanderbilt.edu.

Previously, we reported that a small rat probasin (PB) promoter (-426 to +28 bp, -426PB) would target androgen regulated prostate-specific expression in transgenic mice. Later, we demonstrated that a Large (L) fragment (-10806 to +28 bp, LPB) of the PB promoter would target high levels of gene expression to the prostate in transgenic mice. These results suggested that optimal transcription of the PB gene depended on the presence of enhancer regions upstream of the proximal promoter. To identify these enhancers, the LPB fragment was sequenced and the enhancer activities of restriction fragments were characterized in cell lines. Two non-conventional androgen receptor binding sites (ARBS-3 and ARBS-4) in an upstream androgen-dependent enhancer of the PB gene were identified. One site functions as a weak steroid response element (SRE) in both LNCaP and MCF-7 cells; another site acts as a strong SRE, which preferentially responds to androgen and is preferentially activated in LNCaP cells. These two new ARBSs interact in a cooperative manner with the previously described Androgen Response Region (ARR defined by -244 to -96 bp) that contains ARBS-1, ARBS-2 and two lower affinity AR binding sites G-1 and G-2 sites. We conclude that the context in which the AR binding sites are present is pivotal in determining their effect on transcriptional regulation. Thus, the -705/+28 PB promoter contains a second androgen responsive region, probasin enhancer element (PBE, -705/-426 PB), in addition to the first described ARR. The PB promoter creates a model which contains six AR binding sites that function in a cooperative manner for maximum androgen-regulated prostate-specific gene transcription.


Key words: prostate • probasin • rogen receptor • rogen response element • enhancer







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society